Cargando…
Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis
In this study, a panel of 39 primary malignant fibrous histiocytomas (MFH) of high malignancy grade were characterised for chromosomal alterations. The results were then evaluated in relation to the survival and the occurrence of recurrent disease during follow-up for an average period of 63 months....
Autores principales: | Weng, W-H, Åhlén, J, Lui, W-O, Brosjö, O, Pang, S-T, von Rosen, A, Auer, G, Larsson, O, Larsson, C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376905/ https://www.ncbi.nlm.nih.gov/pubmed/12915885 http://dx.doi.org/10.1038/sj.bjc.6601069 |
Ejemplares similares
-
Malignant Fibrous Histiocytoma, Aggressive Fibromatosis and Benign Fibrous Tumors Express mRNA for the Metalloproteinase Inducer EMMPRIN and the Metalloproteinases MMP-2 and MT1-MMP
por: Åhlén, Jan, et al.
Publicado: (2001) -
Atypical Cutaneous Fibrous Histiocytoma: An Unusual and Misleading Variant of Fibrous Histiocytoma
por: Ben Abdelkrim, Soumaya, et al.
Publicado: (2011) -
Malignant Fibrous Histiocytoma of The Pancreas
por: Garvey, J. F. W., et al.
Publicado: (1989) -
Benign Fibrous Histiocytoma
por: Varma, Pushpa, et al.
Publicado: (2014) -
Operative Technique: Angiomatoid Fibrous Histiocytoma—Unique Case and Management
por: Mazur-Hart, David J., et al.
Publicado: (2022)